Journal
SEPARATIONS
Volume 10, Issue 1, Pages -Publisher
MDPI
DOI: 10.3390/separations10010037
Keywords
brinzolamide; timolol maleate; TLC; HPLC-DAD; oxidative degradation
Categories
Ask authors/readers for more resources
A comparative study was conducted on two stability-indicating chromatographic methods for the assay of brinzolamide and timolol maleate in their ophthalmic formulation, especially in the presence of the probable carcinogenic oxidative degradation product of timolol maleate. The first method involved thin-layer chromatography coupled with densitometric determination, while the second method utilized high performance liquid chromatography with photo diode array detection. Both methods showed good separation and linearity for the analyzed components. The HPLC-DAD method demonstrated superior separation and time-saving results, while the TLC method exhibited higher sensitivity.
A comparative study between two stability-indicating chromatographic methods for the assay of brinzolamide and timolol maleate in the co-existence of the probable carcinogenic oxidative degradation product of timolol maleate in their ophthalmic formulation was demonstrated. The first method established the thin-layer chromatography coupled with the densitometric determination of the analyzed spots, using silica gel TLC aluminum plates F254 and a developing system of chloroform: methanol: ammonia (6:1:0.1, in volumes) at room temperature to give good separation for the three investigated components, where retardation factors for the oxidative degradation product of timolol maleate, brinzolamide and timolol maleate were (Rf 0.21), (Rf 0.46), and (Rf 0.55), respectively. The linear ranges were 2-10 and 3-16 mu g/band for brinzolamide and timolol maleate, respectively. In the second method, high performance liquid chromatography (HPLC), photo diode array detection was used on a Eurospher 5 mu m C18 100 angstrom (4.6 x 250 mm) column, using triethylamine pH 3.5, adjusted by glacial acetic acid: acetonitrile (20:80, v/v) at a rate of 0.5 mL per minute. An acceptable separation was achieved, where the retention times for timolol maleate, the oxidative degradation product of timolol maleate and brinzolamide, were (Rt 3.6), (Rt 4.7), and (Rt 5.6), respectively. Linearity covered a range of 20-120 mu g/mL for both drugs. It has been proved previously that timolol maleate is liable to oxidation, giving a high-probability carcinogenic product in female mice. The validation for the new proposed stability-indicating methods was optimized in line with the ICH guidelines with good outcomes. It is worth noting that the HPLC-DAD method showed superior separation, economic and time-saving results, while TLC method was more sensitive.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available